| 000 | 00887 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513215113.0 | ||
| 264 | 0 | _c20001213 | |
| 008 | 200012s 0 0 eng d | ||
| 022 | _a0270-9295 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBesarab, A | |
| 245 | 0 | 0 |
_aPhysiological and pharmacodynamic considerations for route of EPO administration. _h[electronic resource] |
| 260 |
_bSeminars in nephrology _cJul 2000 |
||
| 300 |
_a364-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnemia, Iron-Deficiency _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 773 | 0 |
_tSeminars in nephrology _gvol. 20 _gno. 4 _gp. 364-74 |
|
| 999 |
_c10877326 _d10877326 |
||